Around the Corner: Digital Health at Scale: The Payor Perspective

Overview



The COVID-19 pandemic has catalyzed efforts by health insurers to expand reimbursement for telehealth services and digital health tools, and develop and invest in their own digital health tools. Health insurers, who increasingly play a hybrid role of payor, innovator and provider, have a vested interest in helping consumers manage chronic diseases and engage in preventive care from home, both during the public health emergency and after.

Join McDermott and leaders from Humana, Oscar and Medorion as we explore the role of health insurers in the evolving digital health market. Topics will include:

  • Pre-pandemic efforts to integrate digital health capabilities into the traditional health insurance framework
  • How the COVID-19 pandemic has impacted coverage for telehealth and digital health tools
  • Digital member engagement before, during and after COVID-19
  • Reimbursement pathways and laws impacting reimbursement
  • Unique health insurer partnerships and investments in technology
  • The outlook for 2021 and beyond

Learn more about this series here.

Speakers


  • Hank Greenberg, General Counsel, Oscar Health
  • Asaf Kleinbort, CEO / Co-Founder, Medorion
  • Elysia Solomon, Deputy General Counsel and Senior VP, Clinical, Technology and Privacy Legal Team, Humana Inc.
  • Marshall E. Jackson, Jr., Partner, McDermott Will & Emery

MODERATOR

  • Kate McDonald, Partner, McDermott Will & Emery

Dig Deeper

Webinar / Speaking Engagements / October 18, 2021

HLTH Boston 2021

Webinar / McDermott Event / October 5 - 6, 2021

DC bio future

Webinar / Speaking Engagements / September 23, 2021

Digital Front Door: Transformation to True Digital Healthcare

London, United Kingdom / Speaking Engagements / September 20-22, 2021

HBI 2021 | New Vistas, New Opportunities

Virtual Event / Speaking Engagements / September 16, 2021

Procuring for Outcomes in an Evolving NHS

Webinar / McDermott Event / July 26, 2021

Exploring Consumer Engagement with Precision Medicine